North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products.

Dividend aristocrat stocks have largely done well in the past few years. The closely-followed ProShares S&P 500 Dividend ...

Drugmaker Abbott India reported a jump in third-quarter profit on Wednesday, helped by strong demand for its gastrointestinal and heart disease medications, sending shares higher. The ...

The governor’s speech sets a broad agenda for the Legislature, including a nuclear renaissance and a Texas Cyber Command.

During this period, the Zacks Medical - Products industry, which Abbott falls in, has gained 9.7%. The key question now is: What could be the stock's future direction? While media releases or rumors ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Abbott Laboratories (NYSE: ABT) is a well-diversified health care company, with four distinct units: medical devices, ...

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.